← Back to Search

Breast cancer decision aid for Breast Cancer

N/A
Waitlist Available
Led By Lesly A Dossett, MD, MPH
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 120-days following surgery
Awards & highlights

Study Summary

This trial is testing a patient guide to help make decisions about breast cancer treatment.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 120-days following surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 120-days following surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention (AIM) Survey
Engagement with the patient decision aid
Intervention Appropriateness Measure (IAM)
Secondary outcome measures
Satisfaction with decision (SWD)
Treatment choice

Trial Design

1Treatment groups
Experimental Treatment
Group I: Breast cancer decision aidExperimental Treatment1 Intervention
Participants receive a breast cancer decision aid.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Breast cancer decision aid
2022
N/A
~30

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
292 Previous Clinical Trials
24,095 Total Patients Enrolled
32 Trials studying Breast Cancer
3,966 Patients Enrolled for Breast Cancer
Lesly A Dossett, MD, MPHPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center

Media Library

Breast cancer decision aid Clinical Trial Eligibility Overview. Trial Name: NCT05140252 — N/A
Breast Cancer Research Study Groups: Breast cancer decision aid
Breast Cancer Clinical Trial 2023: Breast cancer decision aid Highlights & Side Effects. Trial Name: NCT05140252 — N/A
Breast cancer decision aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT05140252 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant positions available to participate in this experiment?

"Affirmative. Clinicaltrials.gov registers that this research project, which was originally published on May 12th 2022, is now actively recruiting individuals for participation. The trial is aiming to enroll 40 patients at a single site."

Answered by AI

How many individuals are participating in this clinical trial?

"Affirmative. Clinicaltrials.gov contains evidence that this clinical research is presently recruiting participants, with an initial posting on May 12th 2022 and a most recent update occurring August 31st of the same year. 40 volunteers are being sought from 1 medical centre for participation in the trial."

Answered by AI
~8 spots leftby Mar 2025